Delisting risk
Virax Biolabs Group (VRAX)
Develops T-cell immune profiling for post-infection syndromes and sells research-use immune reagents.
$2.54
Pre-market−0.02 (−0.78%)
At close$2.56(−1.54%)
Something off on this page? Send us feedback.
Next report
Dec 2, 2026
estimated · in 90 days
EPS estimate
−$1.75
Revenue estimate
$12.4K
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Jan '24Aug '24Nov '24Nov '24Nov '25Dec '25Jul '26Dec '26
Reported−$41.00−$42.75−$0.89−$22.25−$19.00−$12.25—Pending
Estimate————−$8.50−$0.10−$1.75−$1.75
Surprise————−123.5%−12,150.0%——
RevenueReportedEstimate
Jan '24Aug '24Nov '24Nov '24Nov '25Dec '25Jul '26Dec '26
Reported$76.5K$79.9K$5.0K$5.0K$1.4K$2.0K$10.8KPending
Estimate$400.0K$1.0M$3.0M$3.0M$5.0M$10.0M$1.3K$12.4K
Surprise−80.9%−92.0%−99.8%−99.8%−100.0%−100.0%+726.6%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$1.75 | — | — |
| Jul 2026 | −$1.75 | — | — |
| Jun 2026 | −$0.07 | — | — |
| Dec 2025 | −$0.10 | −$12.25 | −12,150.0% |
| Nov 2025 | −$8.50 | −$19.00 | −123.5% |
| Nov 2024 | — | −$22.25 | — |
The latest year is open to everyone — the 13 quarters behind it read with an account. Sign in | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jan 2024 | |||
| Sep 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Feb 2023 | |||
| Sep 2022 | |||
| Aug 2022 | |||
| Sep 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | −$1.75 | — | — | $12.4K | — | — | — |
| Jul 1, 2026 | −$1.75 | — | — | $1.3K | $10.8K | +726.6% | +14.2% |
| Jun 3, 2026 | −$0.07 | — | — | $1.4K | — | — | — |
| Dec 2, 2025 | −$0.10 | −$12.25 | −12,150.0% | $10.0M | $2.0K | −100.0% | +75.2% |
| Nov 1, 2025 | −$8.50 | −$19.00 | −123.5% | $5.0M | $1.4K | −100.0% | −3.6% |
| Nov 20, 2024 | — | −$22.25 | — | $3.0M | $5.0K | −99.8% | +3.2% |
The latest year is open to everyone — the 13 quarters behind it read with an account. Sign in | |||||||
| Nov 19, 2024 | |||||||
| Aug 20, 2024 | |||||||
| Jan 12, 2024 | |||||||
| Sep 30, 2023 | |||||||
| Sep 27, 2023 | |||||||
| Jun 14, 2023 | |||||||
| Feb 2, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Aug 12, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Mar 31, 2020 | |||||||